US2008300394A1PendingUtilityA1

Defective sindbis viral vectors

Assignee: UNIV NEW YORKPriority: Mar 29, 2005Filed: May 20, 2008Published: Dec 4, 2008
Est. expiryMar 29, 2025(expired)· nominal 20-yr term from priority
A61P 35/02A61P 35/00C12N 2770/36143C12N 2770/36122C07K 14/005A61P 43/00A61K 35/76C12N 7/00A01K 2267/0331C12N 2840/203C12N 2770/36161C12N 15/86C12N 2770/36132
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed herein are new defective Sindbis viral vectors made from wild type Ar-339 Sindbis virus, with differences in replicase and envelope proteins between JT vectors and consensus Sindbis virus sequences, and also between JT and Ar-339 vectors. Also disclosed are plasmids used for the production of the vectors, methods for producing the vectors, methods for treating mammals suffering from tumors and pharmaceutical formulations for use in the treatment methods.

Claims

exact text as granted — not AI-modified
1 . A purified, isolated nucleic acid comprising the nucleotide sequence as set forth in nucleotides 1-4831 of SEQ ID NO.: 36. 
     
     
         2 . The nucleic acid of  claim 1 , further comprising a bacteriophage promoter. 
     
     
         3 . The nucleic acid of  claim 2 , further comprising a bacterial antibiotic resisitance gene. 
     
     
         4 . The nucleic acid of  claim 3  wherein said promoter is the T7 promoter. 
     
     
         5 . The nucleic acid of  claim 3  wherein said promoter is the SP6 promoter. 
     
     
         6 . A purified, isolated nucleic acid comprising the nucleotide sequence as set forth in nucleotides 1-8048 as set forth in SEQ ID NO.: 39. 
     
     
         7 . The nucleic acid of  claim 6 , further comprising a bacteriophage promoter. 
     
     
         8 . The nucleic acid of  claim 7 , further comprising a bacterial antibiotic resistance gene. 
     
     
         9 . The nucleic acid of  claim 7  wherein said promoter is the T7 promoter. 
     
     
         10 . The nucleic acid of  claim 7  wherein said promoter is the SP6 promoter. 
     
     
         11 . A purified, isolated nucleic acid comprising a nucleic acid consisting of nucleotides 1-4831 as set forth in SEQ ID NO.: 36. 
     
     
         12 . A purified, isolated nucleic acid comprising a nucleotide sequence consisting of nucleotides 1-4831 as set forth in SEQ ID NO.: 36 and a bacteriophage promoter. 
     
     
         13 . A purified, isolated nucleic acid comprising a nucleotide sequence consisting of nucleotides 1-4831 as set forth in SEQ ID NO.: 36, a bacteriophage promoter and a bacterial antibiotic resistance gene. 
     
     
         14 . A purified, isolated nucleic acid comprising a nucleotide sequence consisting of nucleotides 1-8048 as set forth in SEQ ID NO.: 39. 
     
     
         15 . A purified, isolated nucleic acid comprising a nucleotide sequence consisting of nucleotides 1-8048 as set forth in SEQ ID NO.: 39 and a bacteriophage promoter. 
     
     
         16 . A purified, isolated nucleic acid comprising a nucleotide sequence consisting of nucleotides 1-8048 as set forth in SEQ ID NO.: 39, a bacteriophage promoter and a bacterial antibiotic resistance gene.

Join the waitlist — get patent alerts

Track US2008300394A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.